12:00 AM
 | 
Sep 28, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Abbott Prism HIV O Plus assay regulatory update

FDA approved a BLA from Abbott for its Abbott Prism HIV O Plus assay as a screening tool to detect antibodies...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >